Crystalys Therapeutics Inc.

About Crystalys Therapeutics Inc.

Crystalys Therapeutics is dedicated to addressing significant unmet medical needs for people living with gout. Their mission is to develop new therapeutics and improve patients' lives through a passionate pursuit of excellence in medicine.

Products & Services

Therapeutics for Gout: Developing new treatments aimed at transforming the management and care of gout patients.

Specialties

Gout Treatment Therapeutic Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 205000000 MR: - FA: $205 million FAN: 205000000	D: 2025-10-01 FD: 2025-10-01	13 investors
2	RT: Series A T: - FT: Series A	A: 205000000 MR: - FA: 205 million FAN: 205000000	D: 2025-09-30 FD: 2025-09-30	13 investors

Series A Latest

2025-10-01

$205.0M

13 investors (Pro only)

Series A 2025-09-30

$205.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

James Mackay

President & Chief Executive Officer

LinkedIn (Pro only)

N

Nihar Bhakta

Chief Medical Officer

LinkedIn (Pro only)

A

Ashwin Ram

Chief Operating Officer

LinkedIn (Pro only)

D

DeAnne Reid

Executive Director, Operations & Business Development

B

BT Slingsby

Co-Founder and Executive Chairman

K

Kenneth Harrison

Novo Holdings

View 6 more team members with Pro

Unlock Full Team Directory

Recent News